Camp4 Therapeutics (CAMP) EPS (Weighted Average and Diluted) (2023 - 2026)
Camp4 Therapeutics recorded quarterly EPS (Weighted Average and Diluted) of -$0.32 in Q1 2026, up 63.22% quarter-over-quarter from -$0.87 in Q4 2025, and up 48.39% year-over-year from -$0.22 in Q1 2025.
Camp4 Therapeutics' EPS (Weighted Average and Diluted) history runs 4 years deep, the most recent figure standing at -$0.32 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 48.39% year-over-year to -$0.32; the TTM figure through Mar 2026 stood at -$2.36 (down 116.11% YoY), while the FY2025 annual figure was -$2.65, up 76.0% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.32 for Q1 2026 at Camp4 Therapeutics, up from -$0.87 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $65.46 in Q4 2024 to a low of -$30.18 in Q4 2023.
- A 4-year average of -$6.7 and a median of -$0.87 in 2025 frame the typical range for EPS (Weighted Average and Diluted).
- Across the five-year window, EPS (Weighted Average and Diluted) surged 316.9% in 2024 and slumped 101.33% in 2025, its largest moves.
- Camp4 Therapeutics' EPS (Weighted Average and Diluted) stood at -$30.18 in 2023, then jumped by 316.9% to $65.46 in 2024, then plunged by 101.33% to -$0.87 in 2025, then soared by 63.22% to -$0.32 in 2026.
- According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods registered -$0.32, -$0.87, and -$0.55 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -4.43 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,086.42 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.02 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.75 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.51 |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | -0.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.32 |
| Dec 31, 2025 | -0.87 |
| Sep 30, 2025 | -0.55 |
| Jun 30, 2025 | -0.62 |
| Mar 31, 2025 | -0.62 |
| Dec 31, 2024 | 65.46 |
| Sep 30, 2024 | -24.19 |
| Jun 30, 2024 | -26.00 |
| Mar 31, 2024 | -26.57 |
| Dec 31, 2023 | -30.18 |
| Sep 30, 2023 | -29.21 |